Diagnosing Dry Eye with Lipview II
The eye examination and patient history are important in determining the presence of dry eye. Recent advancements in testing aid in the detection of and categorizing dry eye. More accurate testing also helps to guide and objectively measure treatment progress for dry eye.
Using Lipiview II, the doctors at Durrie Vision can better analyze meibomian gland structure and function. Meibomian gland disease, or irregular lipid layer production of tears, is responsible for the majority of dry eye. LipiView II Dynamic Meibomian gland imaging accurately monitors meibomian gland structure, blink rate and the lipid layer measurements of the tear film.
Lipiview II allows earlier detection for meibomian gland dysfunction. Blocked glands become damaged, and may eventually deteriorate or atrophy. Atrophy is a late consequence of untreated dry eye. Once atrophy occurs, the damage can no longer be repaired. Treatment, such as with Lipiflow, is more successful in patients with the milder form of the disease, before atrophy occurs. Earlier intervention in dry eye aims to keep patients from progressing to the more advanced, end-stages of dry eye disease. Patients with advanced meibomian gland dysfunction can still receive dry eye treatments to improve symptoms, but must continually manage chronic dry eye. Advanced, chronic dry eye has no cure.